Fingerprint
Dive into the research topics of 'A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: An NCCTG study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: An NCCTG study
C. X. Ma, P. Steen, K. M. Rowland, R. D. Niedringhaus, T. R. Fitch, J. W. Kugler, D. W. Hillman, E. A. Perez, J. N. Ingle, Alex A. Adjei
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations